Carvalheira Gianna, Nozima Bruno Heidi, Cerutti Janete Maria
Genetic Bases of Thyroid Tumors Laboratory, Division of Genetics, Department of Morphology and Genetics, Universidade Federal de São Paulo, SP, Brazil.
Oncotarget. 2015 Sep 29;6(29):28357-70. doi: 10.18632/oncotarget.4947.
We previously showed that C1orf24 expression is increased in thyroid carcinomas. Nonetheless, the mechanism underlying C1orf24 deregulation is not fully understood. It has been widely demonstrated that microRNAs are involved in post-transcriptional gene regulation in several diseases, including cancer. Using in silico prediction approach, five microRNAs that bind to the 3'-untranslated region (3'-UTR) of C1orf24 were identified. The expression of two selected microRNAs (miR-17-5p, miR-106b) and the expression of C1orf24 were tested in 48 benign and malignant thyroid lesions and in five thyroid carcinoma cell lines. miR-106b was down-regulated in thyroid cancer specimens and thyroid carcinoma cell lines, while C1orf24 expression was markedly increased. To demonstrate that miR-106b reduces C1orf24 expression, follicular (WRO) and papillary (TPC1) thyroid carcinoma cell lines were transiently transfected with miR-106b mimic. Ectopic expression of the miR-106b mimic significantly inhibits C1orf24 mRNA and protein expression in both WRO and TPC1 cells. Dual-luciferase report assays demonstrated that miR-106b directly targets C1orf24 by binding its 3'-UTR. Moreover, miR-106b-mediated down-regulation of C1orf24 expression increased apoptosis and inhibited migration. We additionally demonstrated that siRNA against C1orf24 significantly decreased its expression, inhibited cell migration and cell cycle progression while induced apoptosis. In summary, our findings not only provide new insights into molecular mechanism associated with C1orf24 overexpression in thyroid carcinomas but also show that C1orf24 might increase proliferation and cell migration. Thus, decreasing C1orf24 levels, by restoring miR-106b function, may have therapeutic implications.
我们之前的研究表明,C1orf24在甲状腺癌中的表达增加。然而,C1orf24失调的潜在机制尚未完全明确。大量研究表明,微小RNA参与了包括癌症在内的多种疾病的转录后基因调控。通过计算机预测方法,我们鉴定出了5种与C1orf24的3'-非翻译区(3'-UTR)结合的微小RNA。我们检测了48例良性和恶性甲状腺病变组织以及5种甲状腺癌细胞系中两种选定的微小RNA(miR-17-5p、miR-106b)的表达以及C1orf24的表达。miR-106b在甲状腺癌标本和甲状腺癌细胞系中表达下调,而C1orf24的表达则显著增加。为了证明miR-106b可降低C1orf24的表达,我们用miR-106b模拟物瞬时转染了滤泡性(WRO)和乳头状(TPC1)甲状腺癌细胞系。miR-106b模拟物的异位表达显著抑制了WRO和TPC1细胞中C1orf24的mRNA和蛋白表达。双荧光素酶报告基因检测表明,miR-106b通过结合其3'-UTR直接靶向C1orf24。此外,miR-106b介导的C1orf24表达下调增加了细胞凋亡并抑制了细胞迁移。我们还证明,针对C1orf24的小干扰RNA(siRNA)显著降低了其表达,抑制了细胞迁移和细胞周期进程,同时诱导了细胞凋亡。总之,我们的研究结果不仅为甲状腺癌中与C1orf24过表达相关的分子机制提供了新的见解,还表明C1orf24可能促进细胞增殖和迁移。因此,通过恢复miR-106b的功能来降低C1orf24的水平可能具有治疗意义。